All News

Viral/Non-Viral Vectors

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 
17 October 2024
Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 
Watch this on-demand webinar to
Cell and Gene Therapies News Round-Up: October 11
11 October 2024
Cell and Gene Therapies News Round-Up: October 11
Welcome to Phacilitate’s weekly news
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
14 May 2024
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
25 March 2024
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
Discover revolutionary advancements in LVV
POPULAR NEWS ITEMS
Image
10 January 2025

Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate

Image
26 November 2024

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image
19 November 2024

Texas Cell and Gene Manufacturing Landscape

Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
29 February 2024
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
Sharmilee Patel, Head of Business
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
26 February 2024
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
Are you interested in editing
In Conversation with Jake Lesnik: An Innovative Solution to <i>ex vivo</i> Delivery Challenges
22 February 2024
In Conversation with Jake Lesnik: An Innovative Solution to ex vivo Delivery Challenges
Jake Lesnik, VP of Business
Overcoming Connectivity and Scalability Challenges with Gene Therapy Manufacturing Processes
7 February 2024
Overcoming Connectivity and Scalability Challenges with Gene Therapy Manufacturing Processes
Dan UpDyke, Strategic Marketing Manager
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate

Image

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image

Texas Cell and Gene Manufacturing Landscape